MILO/ENGOT-ov11: Phase-3 study of binimetinib versus physician's choice chemotherapy (PCC) in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum Meeting Abstract
| Authors: | Grisham, R.; Monk, B. J.; Banerjee, S.; Coleman, R. L.; Oza, A. M.; Oehler, M. K.; Kalbacher, E.; Mirza Raza, M.; del Campo, J. M.; Marth, C.; Westermann, A.; Pignata, S.; Colombo, N.; Cibula, D.; Hilpert, F.; Aghajanian, C.; Drill, E.; Sandor, A. V.; Boyd, P. A.; Vergote, I. |
| Abstract Title: | MILO/ENGOT-ov11: Phase-3 study of binimetinib versus physician's choice chemotherapy (PCC) in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum |
| Meeting Title: | 2019 IGCS Annual Global Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 29 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2019 Sep 19-21 |
| Meeting Location: | Rio de Janeiro, Brazil |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2019-09-01 |
| Start Page: | A1 |
| Language: | English |
| ACCESSION: | WOS:000491998200002 |
| DOI: | 10.1136/ijgc-2019-IGCS.1 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1 -- Source: Wos |
